Cullinan Therapeutics
CGEM
Reported
Thursday, February 27
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.80 | -0.73 | 0.07 | 8.75% |
| Revenue | - | 0.00 | - | - |
WhatIF - Earnings
EPS Beat Expectations by $0.07
Cullinan Therapeutics (CGEM:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything